journal article·2021-01Open access

Antitumor activities of carboplatin–doxorubicin–ZnO complexes in different human cancer cell lines (breast, cervix uteri, colon, liver and oral) under UV exposition

Suttirak Pairoj, Pattareeya Damrongsak, Badin Damrongsak, Natini Jinawath, Rossukon Kaewkhaw, Chinnapat Ruttanasirawit, Tanaporn Leelawattananon, Kitsakorn Locharoenrat

Abstract

This study aimed to examine the pharmacological profiles of multiple chemo drug candidates in systematic circulation to enhance their specific interactions with five human cancer cell lines. ZnO nanoparticles were successfully bound with chemo drugs via physical adsorption. The drug loading capacity was confirmed by FTIR, whereas the loading efficiency was determined via UV-vis spectrometry. The mean hydrodynamic size increased to 69-82 nm after chemo-drug immobilization via non-covalent interaction with ZnO. Among the nine formulated chemo drugs, the carboplatin (CP)-doxorubicin (DOX)-ZnO complex under UV light irradiation exhibited high sensitivity towards human breast adenocarcinoma cells without affecting human keratinocyte immortal cells with an IC50 of 0.137 µg/mL, whereas the loading capacity and efficiency of CP-DOX-ZnO were 77.81% and 99.05%, respectively. Fluorescence images confirmed that CP-DOX-ZnO using DOX served as a fluorescence enhancer specifically bound onto the cell membranes, which became almost saturated after 24 h incubation. Carboplatin-DOX-ZnO was possibly endocytosed by cancer cells and was selectively internalized into the target cells; thus, free chemo drug was released in the cytoplasm, which induced acute apoptosis. This resulted in complete inhabitation of growth signal of target cancer cells.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Metal complexes synthesis and properties · Synthesis and Characterization of Heterocyclic Compounds

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Physics, Faculty of Science, Biomedical Physics Research Unit, King Mongkut’s Institute of Technology Ladkrabang, Bangkok, Thailand

Department of Physics, Faculty of Science, Silpakorn University, Nakornpathom, Thailand

Program in Translational Medicine, Faculty of Medicine Ramathibodi Hospital, Bangkok, Thailand

Funding

King Mongkut’s Institute of Technology Ladkrabang, Bangkok 10520, Thailand

References (37)

Show source-provided references
1. 10.1136/bjophthalmol-2011-30082910.1136/bjophthalmol-2011-300829 ↗
2. 10.3390/molecules2505111010.3390/molecules25051110 ↗
3. 10.1371/journal.pone.023509010.1371/journal.pone.0235090 ↗
4. 10.1080/21691401.2019.167768110.1080/21691401.2019.1677681 ↗
5. 10.1080/10717544.2019.166745210.1080/10717544.2019.1667452 ↗
6. 10.1016/j.msec.2019.11059410.1016/j.msec.2019.110594 ↗
7. 10.1080/10717544.2018.155635910.1080/10717544.2018.1556359 ↗
8. 10.1016/j.msec.2019.11010010.1016/j.msec.2019.110100 ↗
9. 10.3892/ijo.2020.505210.3892/ijo.2020.5052 ↗
10. 10.2217/bmt-2019-001810.2217/bmt-2019-0018 ↗
11. 10.1186/s12885-019-5939-z10.1186/s12885-019-5939-z ↗
12. 10.9734/jpri/2019/v27i63018810.9734/jpri/2019/v27i630188 ↗
13. 10.1002/ccr3.254610.1002/ccr3.2546 ↗
14. 10.1093/molehr/gaaa00810.1093/molehr/gaaa008 ↗
15. 10.21873/anticanres.1429410.21873/anticanres.14294 ↗
16. 10.1016/S1470-2045(19)30408-510.1016/S1470-2045(19)30408-5 ↗
17. 10.1530/REP-19-027910.1530/REP-19-0279 ↗
18. 10.1016/j.urols.2016.08.00110.1016/j.urols.2016.08.001 ↗
19. Eroglu O, Kaya H, Celik EG, et al. Triple effect of doxorubicin, 5-fluorouracil, propranolol on cell survival on MCF-7 breast cancer cell line. J Biosci Med. 2019;7(2):74–85.
20. 10.1096/fasebj.2020.34.s1.0072410.1096/fasebj.2020.34.s1.00724 ↗
21. 10.1007/s12038-019-9845-y10.1007/s12038-019-9845-y ↗
22. 10.1016/j.bbe.2019.08.00410.1016/j.bbe.2019.08.004 ↗
23. Locharoenrat K, Srivatcharakul S. Optical studies of zinc oxide nanoparticles and their biomedical application. Chin J Phys. 2015;53(4):80901.
24. 10.1201/978100305588410.1201/9781003055884 ↗
25. 10.1016/j.ijbiomac.2019.11.00310.1016/j.ijbiomac.2019.11.003 ↗
26. 10.1016/j.materresbull.2017.05.04310.1016/j.materresbull.2017.05.043 ↗
27. 10.17219/pim/12837810.17219/pim/128378 ↗
28. 10.1166/jctn.2017.692010.1166/jctn.2017.6920 ↗
29. Iliescu RI, Andronescu E, Ghitulica CD, et al. Montmorillonite–alginate nanocomposite beads as drug carrier for oral administration of carboplatin – preparation and characterization. UPB Sci Bull B. 2011;73(3):3–16.
30. 10.2217/nnm.16.510.2217/nnm.16.5 ↗
31. Harahap Y, Amalia SN, Anarta A. Analysis of doxorubicin and doxorubicinol in dried blood spot of breast cancer patients for monitoring the cardiotoxicity of doxorubicin. Int J Pharmacy Pharm Sci. 2020;12(4):36707.
32. 10.1016/j.ejps.2018.01.02710.1016/j.ejps.2018.01.027 ↗
33. 10.1016/j.jddst.2019.10120010.1016/j.jddst.2019.101200 ↗
34. Jefri SNS, Abdullah AH, Mohammad EN. Response surface methodology: photodegradation of methyl orange by CuO/ZnO under UV light irradiation. Asian J Green Chem. 2019;3(2):271–287.
35. 10.1007/s10854-017-8039-310.1007/s10854-017-8039-3 ↗
36. 10.1007/s41742-018-0064-410.1007/s41742-018-0064-4 ↗
37. 10.1007/s10854-017-7199-510.1007/s10854-017-7199-5 ↗